| __timestamp | Alnylam Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 51256000 |
| Thursday, January 1, 2015 | 41097000 | 77347000 |
| Friday, January 1, 2016 | 47159000 | 104189000 |
| Sunday, January 1, 2017 | 76545000 | 90795000 |
| Monday, January 1, 2018 | 73106000 | 106985000 |
| Tuesday, January 1, 2019 | 194688000 | 131923000 |
| Wednesday, January 1, 2020 | 414801000 | 143340000 |
| Friday, January 1, 2021 | 704143000 | 199739000 |
| Saturday, January 1, 2022 | 868601000 | 248860000 |
| Sunday, January 1, 2023 | 1517886000 | 351121000 |
| Monday, January 1, 2024 | 1924873000 |
Infusing magic into the data realm
In the dynamic world of biopharmaceuticals, Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Alnylam's gross profit surged by an impressive 2,900%, peaking at approximately $1.5 billion in 2023. This growth reflects their strategic advancements in RNA interference therapeutics. In contrast, Amphastar's gross profit grew by 585% during the same period, reaching around $351 million in 2023, showcasing their steady expansion in generic and specialty pharmaceuticals.
This analysis underscores the diverse strategies and market dynamics shaping the biopharmaceutical industry today.
Who Generates Higher Gross Profit? Novo Nordisk A/S or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: AbbVie Inc. vs Amphastar Pharmaceuticals, Inc.
Sanofi vs Alnylam Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Alnylam Pharmaceuticals, Inc. and Biogen Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Ascendis Pharma A/S
Alnylam Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc. Trends
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? MorphoSys AG or Amphastar Pharmaceuticals, Inc.